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Abstract
The study of porcine endogenous retroviruses (PERVs) becomes increasingly important due to the potential use of pig cells, tissues, and
organs as a source for xenogenic cell therapy and xenotransplantation into humans. Consequently, we have constructed a plasmid that
induces in bacteria the synthesis of a soluble and highly active reverse transcriptase (RT) of PERV-B. The purified PERV RT was studied
biochemically in comparison with the RT of murine leukemia virus (MLV), because of the high-sequence homology between these two RTs.
The data show that in several properties the two enzymes are similar, particularly regarding the monomeric subunit composition of the
proteins in solution, the high resistance to deoxynucleoside analogues, and the pattern of RNA cleavage by the ribonuclease H activity
(RNase H) of the RTs. However, in several cases there are apparent differences between the two RTs, most notable the divalent cation
preference (Mn2 versus Mg2) in the DNA polymerase reactions. As already shown for viral PERV RT, the novel recombinant PERV RT
exhibits a relatively high resistance to several deoxynucleoside analogue inhibitors, suggesting that they might not be very efficient in
inhibiting the replication of PERV virions. Therefore, the availability of large amounts of the recombinant RT can be useful for a wide
screening of novel drugs against infectious PERV.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The use of animal cell, tissue, and organ transplants into
humans offers a potential solution to the very limited supply
of allographs in the treatment of human disorders (White
and Nicolson, 1999). Among the animals tested for xeno-
transplantation, pigs are considered to be a preferred source
for a variety of reasons. These include the availability, the
size of the organs, the development of strategies to over-
come rejection by the immune system of the recipient, and
the development of novel genetic manipulations of the pigs
to reduce rejection (Cooper et al., 2002). Growing pigs
under specific pathogen-free conditions is required to re-
duce potential risks of transmitting a variety of infectious
agents into the human recipients. Since pigs exhibit a rela-
tively low load of exogenous microorganisms when grown
under these conditions, this problem might be a relatively
mild one. On the other hand, there are endogenous retroviral
sequences permanently integrated in multiple copies into
the pig genome. These porcine endogenous retroviruses
(PERVs) show sequence homology to the C-type mamma-
lian retroviruses, the murine, feline, and gibbon ape leuke-
mia viruses (MLV, FeLV, and GaLV, respectively), all of
which induce leukemias and immunodeficiencies in the in-
fected hosts (Le Tissier et al., 1997; Patience et al., 1997;
Takeuchi et al., 1998).
Three major groups of PERVs were identified so far,
depending on the envelope proteins of the viruses, PERV-A,
PERV-B, and PERV-C. These viruses show a distinct re-
ceptor specificity and in vitro cell tropism (Wilson et al.,
2000). Nonetheless, their reverse transcriptase (RT) and
protease sequences are practically indistinguishable.
PERV-A and PERV-B were shown to infect productively
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human cells in vitro (Akiyoshi et al., 1998; Patience et al.,
1997; Takeuchi et al., 1998). In general, infections by C-
type retroviruses can result in a variety of clinical manifes-
tations in the infected animals (from benign to neoplastic
and neurological diseases). Therefore, there is a potential
risk for human recipients of pig cells, tissues, or organs to
develop such retrovirus-related diseases. Moreover, there
might also be a risk that such infections could be passed
further from the xenotransplant recipient to people in close
contact (Stoye et al., 1998). As retroviral RTs are the major
targets for anti-retroviral drugs, as is clearly the case of
human immunodeficiency virus (HIV) that causes acquired
immunodeficiency syndrome (AIDS), it is important to
study the RT of PERV (and to develop drugs effective
against the potential infections by PERVs).
Reverse transcriptase is a key enzyme in the life cycle of
all retroviruses (Coffin et al., 1997; De Clercq, 1997; Skalka
and Goff, 1993). Replication of these viruses starts with the
reverse transcription of the single-stranded viral RNA ge-
nome to double-stranded DNA, which is subsequently inte-
grated into the host cell chromosomal DNA. The compli-
cated process of reverse transcription is catalyzed entirely
by RT. The plus-strand RNA genome is copied by the
RNA-dependent DNA polymerase (RDDP) activity of RT,
producing RNA  DNA heteroduplexes. Concomitant with
this synthesis, the ribonuclease H (RNase H) activity of RT
specifically hydrolyzes the RNA strand in these RNA  DNA
hybrids and the remaining DNA strand is copied into a
complementary DNA strand by the DNA-dependent DNA
polymerase (DDDP) activity of RT (generating double-
stranded DNA). Due to its critical role in retroviral replica-
tion, inhibitors of RT are effective in inhibiting viral prop-
agation (Coffin et al., 1997). It was also found recently that
several RT inhibitors are capable of suppressing PERV
growth in vitro (Qari et al., 2001; Stephan et al., 2001).
We report here on the expression in bacteria of a recom-
binant PERV RT for the first time. This RT is derived from
a PERV-B molecular clone, which produces infectious and
replication-competent virions after transfecting the human
embryonic kidney cell line 293 (Czaudera et al., 2000). Due
to the relatively high sequence homology between the novel
PERV RT and MLV RT, a comparative study on the cata-
lytic and molecular properties of these two RTs is con-
ducted. The recombinant PERV RT shows high catalytic
activities resembling in most cases those of MLV RT.
Results
Expression of PERV RT in bacteria
The rationale for the design of the vector expressing the
recombinant PERV RT was based on the sequence similar-
ity with MLV RT (Fig. 1), thus predicting the amino- and
carboxyl-termini of the PERV RT protein. A comparison
between the pol genes of both MLV and PERV revealed
that the best fit between MLV RT (671 amino acids in
length) and PERV RT might be obtained with a PERV RT,
which is 667 amino acids in length. This protein starts with
the Thr-Leu-Gln-Leu-Asp- sequence at its amino-terminus
and ends with -Asn-Leu-Leu-Pro-Ile at its carboxyl-termi-
nus. We have included in this sequence the two residues,
Pro-Ile, beyond the carboxyl-terminus of MLV RT, to com-
pensate for the gap of the five residues (661–665) that are
missing in PERV RT (see Fig. 1). The DNA fragment
encoding this polypeptide was amplified from the plasmid
pPERV-B(33)ATG with the PERV provirus, using standard
PCR techniques. The upstream synthetic oligonucleotide
introduces an SphI recognition site that contains the trans-
lational initiation codon ATG. To preserve the SphI site and
to retain the amino-terminal threonine of PERV RT, we
made an upstream amplification by using an oligonucleotide
that includes a second CTG (leucine) codon next to the
ATG initiation codon. Consequently, the amino-terminal
sequence of the recombinant protein contains two extra
amino acids, Met-Leu, preceding the Thr-Leu-Gln sequence
predicted. The downstream synthetic oligonucleotide had a
TAG termination codon 3 to the last codon for the RT,
followed by the SalI recognition sequence. The PCR-am-
plified fragment was cleaved with SphI and SalI and in-
serted into SphI-SalI-cleaved pUC112N6H(SphI) plasmid
(an expression vector with the six-histidines tag-coding se-
quence). Consequently, the fully expressed RT possesses a
six-histidines tag at its amino-terminus followed by the
sequence described, as done for other RTs (Perach and Hizi,
1999; Taube et al., 1988a). The validity of the RT-encoding
genome was confirmed by DNA sequencing.
Purification of PERV RT
The bacterial clone harboring the RT-expressing plasmid
was analyzed for the expression of PERV RT. This plasmid
induced the synthesis of an approximately 72-kDa polypep-
tide, compatible with the expected full length of the recom-
binant protein (Fig. 2). The PERV RT was purified to
homogeneity, employing the Ni-NTA agarose affinity chro-
matography (to bind the six-histidines-containing protein),
followed by carboxymethyl–Sepharose ion-exchange chro-
matography (Fig. 2 and Table 1), as described earlier for
other RTs (Perach and Hizi, 1999; Sevilya et al., 2001;
Taube et al., 1998a). A partial enrichment of the recombi-
nant PERV RT has been obtained in the first purification
step with a large increase (of about 75-fold) in the total
DNA polymerase activity, and a larger increase (of 750-
fold) in the specific polymerase activity. As can be seen in
Fig. 2, the second purification step was very efficient in
removing all detectable contaminating bacterial proteins.
A quantitative analysis (Table 1) reveals a second, al-
though a less pronounced, increase in the total DNA
polymerase activity (of about 2.5-fold) accompanied by a
further ninefold increase in the specific polymerase ac-
tivity. At this stage only one detectable polypeptide, with
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an apparent molecular mass of about 72 kDa, can be
observed, which is very similar to the purified MLV RT
(and is larger than the p66 subunit of HIV-1 RT). In all,
the enzyme underwent an extensive purification, with a
massive increase in the specific activity (of approxi-
mately 7000-fold), probably due to the removal of the
bacterial proteins and other inhibitors. This precludes the
calculation of the relative recovery of the PERV RT
during the purification process. We have observed a sim-
ilar phenomenon of an overall increase in the total DNA
polymerase activity while purifying the recombinant RTs
of MMTV (Taube et al., 1998a) and BLV (Perach and
Hizi, 1999).
Subunit composition of the active PERV RT
Several of the RTs studied so far are heterodimers, where
the smaller subunits are derived from the large ones by a
cleavage of their carboxyl-termini by the retroviral protease
(Coffin et al., 1997; Skalka and Goff, 1993). Other RTs,
those of MLV, MMTV, and BLV, are composed of mono-
mers (Perach and Hizi, 1999; Taube et al., 1998a; Tele-
snitsky and Goff, 1993). To establish the subunit structure
of the recombinant active PERV RT in solution, the purified
enzyme was ultracentrifuged through preformed glycerol
linear gradients under non-denaturing conditions, along
with myoglobin as a molecular mass marker (of 16.9 kDa),
Fig. 1. CLUSTAL W pairwise alignment of the amino acids residues of PERV and MLV RTs. The upper lines represent 667-residues-long recombinant
PERV RT and the middle lines represent the 671-residues-long MLV RT. Asterisks in the lower lines mark the identical amino acids. The numbering of the
residues is on the left of each line.
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HIV-1 RT (a heterodimer with a molecular mass of about
110 kDa), and MLV RT (monomer of about 73 kDa). As
shown in Fig. 3, the DNA polymerase activity of PERV RT
sediments as a single peak, which overlaps the MLV RT
peak and is located between the myoglobin and HIV-1 RT
markers. This indicates that PERV RT, similar to MLV RT,
is a monomeric enzyme in solution under the native condi-
tions where HIV-1 RT is a dimer. There was a report that
monomeric MLV RT may dimerize in solution under cer-
tain conditions when active as DNA polymerase (Tele-
snitsky and Goff, 1993), although other studies imply that
MLV RT does not form dimers with RNA or DNA and
stays as a monomer (Misra et al., 1998; Pandey et al., 2001).
We tested whether the recombinant PERV RT is capable of
forming dimers after binding to the DNA substrate. This
RT, which was incubated with a molar excess of double-
stranded DNA prior to the sedimentation analysis, also
sediments as a monomer. However, the RT–DNA complex
sediments slightly faster than free monomeric enzyme (Fig.
3). This phenomenon probably results either from the addi-
tional mass of the DNA (48 bp long) and/or from differ-
ences in the folding of the RT after binding to DNA.
Similarly, complexes of monomeric MMTV RT and BLV
RT sedimented with DNA slightly faster than the free mo-
nomeric RTs (Perach and Hizi, 1999; Taube et al., 1998a).
The relative DNA polymerase activities
The DNA polymerase activities of PERV RT were ana-
lyzed and compared with those of MLV RT in the presence
of either Mn2 or Mg2 as the divalent cation. Similar to all
RTs studied so far, PERV RT lacks a 3 3 5 exonuclease
(proofreading) activity (data not shown), thereby permitting
a direct kinetic analysis of primer extension. Previous data
show that MLV RT prefers Mn2 to Mg2 (Hizi and
Hughes, 1988), and here we show that this preference of
both RTs depends on the substrate of the polymerase activ-
ity assay. The relative specific activities of PERV RT with
a variety of substrates used are presented in Table 2.
The results show that, with the preferable divalent cation,
PERV RT exhibits a specific activity slightly lower than that
observed with MLV RT (for every given template-primer,
except for X174 DNA). A second conclusion is that PERV
RT prefers Mg2 over Mn2 with all template-primers used,
except for poly(rA)n  oligo(dT)12–18, whereas MLV RT exhib-
its a variable preference. Still, MLV RT prefers mostly Mg2
(in five of the seven substrates used for assaying the DDDP
and RDDP activities). As to the specific preferences for the
template-primers employed, both RTs show similar selections.
For RDDP, both RTs exhibit the highest activities with
poly(rA)n  oligo(dT)12–18 and the lowest with rRNA. For
DDDP, the order of preference with the various template-
primers is as follows: poly(dC)n  oligo(dG)12–18  activated
DNA  poly(dA)n  oligo(dT)12–18  X174 DNA.
Steady-state kinetic parameters for the DNA polymerase
activity
The kinetic values for dNTPs incorporation into the
nascent DNA strand were determined for both RTs from the
double reciprocal plots of the initial velocity versus sub-
strate concentration (not shown). For RDDP activity, we
have tested poly(rA)n  oligo(dT)12–18 (with the variable
dTTP) and poly(rC)n  oligo(dG)12–18 (with dGTP). For the
DDDP function, activated gapped double-stranded DNA
was used (with all four dNTPs, of which dTTP and dGTP
were the variable substrates). To examine the kinetic pa-
rameters under optimal conditions, the divalent cation used
Table 1
The quantitative pattern of PERV RT purification from bacterial extracts
Protein
(mg)
DNA
polymerase
activity
(units)
Specific DNA
polymerase
activity (units/
mg protein)
Crude bacterial extract 300 1.3  107 4.3  104 (1)
Ni NTA agarose column
eluate 30.5 9.8  108 3.2  107 (744)
CM-Sepharose column eluate 8.2 2.4  109 2.9  108 (6744)
Note. DNA polymerase activity unit is expressed in pmol of [3H]dTTP
incorporated into TCA-insoluble material for 30 min at 37°C in
poly(rA)n  oligo(dT)12–18 directed reaction as described under Materials
and methods. The different purification steps are described under Results.
The numbers in parentheses are the factor by which the specific RDDP
activity of the purified protein increased relative to that of the crude
bacterial extract.
Fig. 2. SDS–PAGE analysis of the proteins during the purification of the
recombinant PERV RT. The purification of PERV RT was performed as
described under Materials and methods and Results. The fractions were
analyzed by SDS–PAGE; gels were then Coomassie stained. Lane 1,
proteins in crude bacterial extract carrying the PERV RT-expressing plas-
mid. Lane 2, proteins in the eluate after Ni-NTA agarose affinity chroma-
tography. Lane 3, purified PERV RT in the eluate from carboxymethyl–
Sepharose column. Lane 4, pure MLV RT. Lane 5, pure HIV-1 RT.
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in each reaction was the preferable one, namely Mn2 with
poly(rA)n  oligo(dT)12–18 and Mg2 with all the other tem-
plate-primers studied. The results presented in Table 3 show
that PERV RT is somewhat less efficient as a DNA poly-
merase relative to MLV RT, as deduced from the lower
kcat/Km values. This is compatible with the data presented in
Table 2. The lower enzymatic activity of PERV RT results
from both higher Km and lower kcat values relative to those
of MLV RT. Interestingly, most Km values of PERV and
MLV RTs are higher than those of other purified recombi-
nant RTs, i.e., of HIV-1, HIV-2, EIAV, BLV, and MMTV
(Hizi et al., 1991; Perach and Hizi, 1999; Rubinek et al.,
1994; Taube et al., 1998a).
DNA synthesis under processive and nonprocessive
conditions
The length of the nascent polymeric products, formed
before the polymerase molecules dissociate from them, de-
fines the processivity of the enzyme (Avidan and Hizi,
1998; Von Hippel et al., 1994). The extent of product
elongation in one cycle of synthesis depends on parameters
that affect binding, single nucleotide addition, translocation,
pausing, etc. Retroviral RTs are not very efficient in per-
forming totally processive events (Avidan and Hizi, 1998).
We have tested, therefore, the processivity of PERV RT by
examining its capacity to synthesize DNA using single-
strand X174am3 DNA as template (Fig. 4). The extension
of the labeled primer was carried out in the absence or
presence of DNA trap. Excess unlabeled activated DNA
was added after preincubation of the enzymes with the
labeled template-primer (and prior to the addition of all four
dNTPs) to trap the enzyme after its first dissociation from
the template-primer. This prevents further extensions of the
labeled primer by the reassociation of the RT and each
molecule is restricted to only one round of synthesis. As
expected, both PERV and MLV RTs produce longer DNA
products when multiple rounds of synthesis are allowed.
The enzymes used have been calibrated to have equal
DDDP activities with X174am3 DNA and the reactions
were performed in the presence of either Mg2 or Mn2
(Fig. 4). The distribution of the products generated by both
RTs in the absence of the DNA trap shows significant
differences in their response to the divalent cations
present. PERV RT exhibits a significant preference for
Mg2 while extending the primer to products (that reach
Fig. 3. Determination of the molecular size of active PERV RT by ultracentrifugation through glycerol gradients. Linear gradients of 20–35% (v/v) glycerol
were prepared in 30 mM Tris–HCl, 0.1 M NaCl, 0.2% Triton X-100, 20 g/ml BSA, and 5 mM DTT, ultracentrifuged (for 40 h at 150,000 g at 4°C), and
fractionated starting from the top (250 l per fraction), as described in detail previously (Perach and Hizi, 1999; Taube et al., 1998a) . Fractions were assayed
for the RDDP activity of the three RTs. The RT activity was calculated for each fraction as percentages of the total RDDP activity per gradient, in the
poly(rA)n  oligo(dT)12–18-directed reaction. () Free PERV RT. () PERV RT bound to double-stranded 48-nt synthetic oligonucleotide. () Free MLV RT.
(Œ) Free HIV-1 RT. The conditions for the preincubations of the PERV RT with the synthetic DNA were described by us previously (Perach and Hizi, 1999;
Taube et al., 1998a). Myoglobin was added to each centrifuge tube as a molecular size marker. The position of the myoglobin peak (16.9 kDa) was measured
by the absorbance at 410 nm and is indicated by an arrow.
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lengths of up to about 1000 nt or more). However, in the
presence of Mn2, there are hardly any detectable prod-
ucts longer than 100 nt. Contrary to PERV RT, MLV RT
shows a significant preference for Mn2 by generating
long products (most of them longer than 100 nt), while
with Mg2 most products are substantially shorter than
100 nt. These results are comparable with the quantitative
data presented in Table 2 for the specific DDDP activities
with X174am3 DNA as template.
The extension products were also quantified and the
elongation was calculated as a percentage of the total
amount of primers (both unextended and extended prim-
ers—Table 4). The qualitative and quantitative data
indicate that both RTs extend (in the presence of the
preferred divalent cation) the majority of the primer mol-
ecules, when multiple rounds of DNA synthesis are per-
mitted. PERV RT extends a higher proportion of the
primers (about 97%) in the presence of Mg2 compared
to MLV RT in the presence of Mn2 (about 72%). The
majority of the products of both RTs are longer than 100
nt (53 and 48% for PERV and MLV RTs, respectively).
Similar to other RTs studied (Avidan and Hizi, 1998;
Avidan et al., 2002; Taube et al., 1998b), there are
specific pausings during DNA synthesis, which are quite
similar for both RTs analyzed here. These pausing sites
do not depend on whether Mg2 or Mn2 are present. On
the other hand, the length of the products depends sub-
stantially on the divalent cation used. The products gen-
erated with the unfavorable cation are shorter, suggesting
that the translocation (or what we define here as “persis-
tence of synthesis”) is impaired, even when multiple
rounds of synthesis are allowed. As expected, when a
DNA trap is present, and only one round of DNA syn-
thesis is permitted, both RTs synthesize less and shorter
products relative to multiple-round synthesis, in the pres-
ence of both Mg2 or Mn2 (Fig. 4 and Table 4). Addi-
tionally, the ratio calculated for the overall extension
with a trap, over that without a trap (which equals to the
relative overall processivity values), for PERV RT is
slightly higher in the presence of Mn2 (100%) than that
in the presence of Mg2 (95%). Similarly, the processiv-
ity of MLV RT with Mg2 (89%) is somewhat higher
than that with Mn2 (83%). In conclusion, it is apparent
that the overall processivity of DNA synthesis of PERV
RT is moderately higher than that of MLV RT.
Table 2
Specific catalytic activities, substrates, and divalent cation preferences
of PERV RT and MLV RT
RT
activity
Substrate PERV RT MLV RT
Mg2 Mn2 Mg2 Mn2
DDDP dA  dT 288 19 465 22
dC  dG 22,670 2070 29,625 2670
Activated DNA 1661 534 2079 891
x174 DNA 175 38 43 95
RDDP rA  dT 14,095 19,430 8020 27,300
rC  dG 1800 175 6020 872
16S RNA 38 28 170 136
RNase H [3H]rA  dT 59 542 109 536
Note. The specific activities of the DNA polymerases activities are
expressed in pmol of dNTP incorporated into DNA in 30 min at 37°C per
g purified RT. For activated DNA, x174 DNA, and rRNA the dNTP
incorporation was calculated for all four dNTPs, assuming equimolar
incorporation. The specific RNase H activity was expressed in pmol
[3H]AMP released from [3H]poly(rA)n  poly(dT)n in 30 min at 37°C per
g protein (as described under Materials and methods). The effect of
divalent cations on the different catalytic activities was measured with 0.8
mM MnCl2 or 8 mM MgCl2. The values presented are averages calculated
from at least two independent experiments (after subtracting background
levels with no RT present in the reaction) with standard deviation values of
around 10%. The specific activities values marked in bold are the maximal
numbers obtained for each RT (for every given substrate) while comparing
the Mg2-dependent versus the Mn2-dependent reactions.
Table 3
Steady-state kinetic parameters for the DNA polymerase and RNase H activities of PERV RT and MLV RT
rA  dT
(dTTP)
rC  dG
(dGTP)
Activated DNA RNase H
(dTTP) (dGTP)
PERV RT
Km 42.8 33.2 14.2 4.8 0.98
kcat 3.6 0.37 0.33 0.21 0.132
kcat/Km 8.4  104 1.1  104 2.3  104 4.4  104 1.33  105
MLV RT
Km 33.4 12.1 11.3 4.9 1.34
kcat 6.8 0.65 0.37 0.29 0.24
kcat/Km 2.16  105 5.4  104 3.3  104 5.9  104 1.79  105
Note. The RDDP and DDDP and RNase H activities of PERV RT and MLV RT were assayed with the template-primers described, in variable
concentrations of either dTTP, dGTP, or [3H]poly(rA)n  poly(dT)n (for RNase H), as described under Materials and methods (for DNA synthesis). All
reactions were carried out for 10 min at 37°C. The Km and Vmax values were calculated from double reciprocal plots of the various substrate concentrations
against the initial velocities of DNA synthesis or RNA digestion. The plots were generated by linear regression analysis yielding regression coefficients
around 0.99 (not shown). The kcat values are the steady-state rate coefficients calculated from the Vmax values divided by the moles of each enzyme in the
reaction mixtures. Km values are expressed in M of the variable dNTP and the kcat values in s1 and the kcat/Km values in s1M1. In the RNase H activity,
the substrate is expressed as AMP concentrations in the [3H]poly(rA)n  poly(dT)n.
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The RNase H activity
All RTs studied so far have an intrinsic RNase H activity
that is crucial for the process of reverse transcription. Se-
quence and structural analyses have shown that the RNase
H domain is located in the carboxyl-terminus of the RTs,
whereas the DNA polymerase is located at the amino-
terminal portion of the molecule. To confirm the presence of
the RNase H activity in the novel PERV RT and to char-
acterize it, two assay methods were employed (Hizi et al.,
1991; Sevilya et al., 2001). In the first, the release of
[3H]AMP was followed as a result of the digestion of
[3H]poly(rA)n  poly(dT)n. In the second method, the pattern
of cleavage of labeled RNA with a defined length in an
RNA  DNA heteroduplex has been followed (see Materials
and methods).
The data obtained indicate that PERV RT exhibits, sim-
ilar to MLV RT, an RNase H activity with a significant
preference for Mn2 over Mg2 (Table 2 and Fig. 5). It is
also apparent that the specific RNase H activity of the
PERV RT with Mn2 is very similar to that of MLV RT.
This finding was also confirmed by the steady-state kinetic
analysis of the RNase H activity of both RTs (Table 3). The
experiment (performed with the preferred divalent cation,
Mn2) shows that the apparent Km and kcat values, calcu-
lated for the variable [3H]poly(rA)n  poly(dT)n substrate,
Fig. 4. DNA synthesis under processive and nonprocessive conditions exhibited by PERV and MLV RTs. All reactions were performed with the 15-nucleotide
synthetic 5-end-labeled primer and an excess of the template single-stranded circular X174am3 phage DNA. The sequence of the primer is shown in Fig.
6A. The symbols for the DNA synthesis experiments are as follows: () DNA extension performed with no DNA trap; () extension experiments conducted
in the presence of unlabeled DNA trap; (Mg2) reactions with Mg2 as the divalent cation; (Mn2) reactions performed with Mn2. Molecular mass markers
are HinfI-cleaved dephosphorylated double-stranded X174am3 DNA fragments (Promega) labeled with [32P]ATP at the 5 ends by polynucleotide kinase.
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are quite similar for both RTs. Therefore, the kcat/Km values
that express the efficiency of the catalytic process are also
close.
The pattern of the cleavage of the 5 end-labeled 267-nt
RNA was used to characterize the RNase H activity of the
RTs of HIV-1 and HIV-2 (Sevilya et al., 2001). It was found
that these RTs perform two cleavages. First, a primary
cleavage takes place at a position 17–18 nt away from the
position corresponding to the 3 end of the DNA heterodu-
plex (thus producing a 47-nt-long RNA product). Since it is
assumed that the DNA polymerase domain of the RT binds
the 3 end of the DNA primer, this primary cleavage sug-
gests that the molecular distance between the DNA poly-
merase active site and the RNase H active sites equals
17–18 nt. In HIV RTs there is also a secondary RNase H
cleavage at a position that corresponds to 8 nt away from the
3 end of the DNA (producing in this assay 38-nt-long RNA
molecules). This probably results from a secondary reposi-
tioning of the RT molecules in the RNA  DNA heterodu-
plexes after performing the primary cleavage (Gao et al.,
1999; Palaniappan et al., 1996). We have recently found
that the pattern of RNA cleavage by MMTV RT is identical
to that of HIV RTs (Entin-Meer et al., 2002). Fig. 5 shows
the pattern of the RNase H cleavage by PERV RT in
comparison with MLV RT and the well-studied cleavage by
HIV-1 RT (Gao et al., 1999; Sevilya et al., 2001;
Wisniewski et al., 2000). As expected, the kinetics of the
cleavage in the presence of Mn2 is faster than with Mg2
for both PERV and MLV RTs. The primary cleavage by
these two RTs is similar to that of HIV-1 RT, suggesting
that in all three RTs studied the putative molecular distance
between the RNase H and the polymerase active sites is
approximately 17 nt. Unlike HIV-1 RT, which produces
only the 38-nt-long RNA, both PERV and MLV RTs per-
formed several secondary cleavages that produce 42-, 38-,
35-, 33-, and 30-nt-long RNA molecules. This indicates that
the repositioning of the PERV and MLV RT molecules on
the substrate (following the first 17-nt cleavage) is not
restricted to a single 8 nt distance (as in HIV-1 RT) but to
several positions on the RNA substrate that correspond to
12, 8, 5, 3 nt away from the 3 end, in addition to a
position located precisely across the 3 end of the DNA
oligonucleotide. It seems that the secondary cleavages occur
in an ordered manner in which the 12 and 8 nt are the
first ones (followed by the other three cuts closer to the 5
end of the RNA). It is also apparent that the qualitative
pattern of RNase H cleavage with either Mn2 or Mg2 is
quite similar, suggesting that the mechanism of RT reposi-
tioning on the substrate does not depend on the kind of
divalent cation present.
The fidelity of DNA synthesis
We have studied the fidelity of DNA synthesis in vitro
with a variety of retroviral RTs. It was shown that the
parameters for fidelity (i.e., 3-end misinsertion and the
extension of the preformed 3-end mispaired primers) de-
pend primarily on the sequences of nucleic acids copied,
rather than on whether DNA or RNA templates were used
(Bakhanashvili and Hizi, 1993a,b; Rubinek et al., 1997;
Taube et al., 1998b). Consequently, we have analyzed DNA
templates, as representing both DNA and RNA substrates.
Site-specific nucleotide misinsertion
The fidelity of misinsertion was studied in an assay
system that measures the standing-start reaction of 3-end
misinsertion. This was done by following the misincorpo-
ration of incorrect dNTPs opposite to the template A nucle-
Table 4
Quantitative analysis of DNA primer extension
Product length
(nt)
Mg2 Mn2
No trap With trap Ratio No trap With trap Ratio
PERV RT 16–50 25.8  0.3 67.7  3.4 2.6 73.9  2 77.4  1.9 1
51–100 18.2  1.5 19.3  1.3 1 8.9  1.3 7.3  1.3 0.82
101–200 25  1 3.9  2 0.15 3  1.2 1.8  1.1 0.6
201–700 18.1  0.1 1.4  0.8 0.08 0 0 0
701 9.9  0.1 0 0 0 0 0
Overall extension 97.4  0.8 92.3  0.7 0.95 85.8  0.6 86.5  0.5 1
MLV RT 16–50 44.1  0.1 66.6  0.1 1.5 4.8  2.5 52.4  0.5 10.9
51–100 23.2  0.1 0 0 18.4  0.1 7.2  1.4 0.39
101–200 2.4  0.5 0 0 28  0.2 0 0
201–700 1.1  0.4 0 0 13.5  0.1 0 0
701 3.9  0.1 0 0 6.9  0.2 0 0
Overall extension 74.7  0.8 66.6  0.1 0.89 71.6  2.4 59.6  1.9 0.83
Note. The radioactivity in the DNA bands in all polynucleotide length ranges was summed up and the values were subsequently divided by the sums of
all extended and unextended primers (detected by scanning of the autoradiograms as shown in Fig. 4). The values given are the extended primers in each
product length range expressed as percentages of the total amounts (all extended and unextended primers) of the DNA products. The calculations were
conducted separately for gel lanes of reactions carried out in the absence or presence of an excess of the unlabeled DNA trap. The extensions in the presence
of the DNA trap divided by the comparable figures obtained with no trap present yielded the ratio values. The ratios calculated for the overall extensions
are the relative processivity values. The values are the means calculated from two independent experiments (one of which is shown in Fig. 4).
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otide—in comparison with the incorporation of dTTP (see
Fig. 6A and Materials and methods). PERV and MLV RTs
elongate the primer by one nucleotide in the presence of 1
M dTTP with no further extension. The highest extent of
misincorporation by the two RTs is obtained with dCTP,
forming C  A mispairs. Only in the case of PERV RT, this
mispair is further elongated to form C  T mispairs, followed
by the correct C  G pairs (18 nt) and by the C  T mispair
(19 nt). With the other two wrong dNTPs, there is very little
misincorporation by MLV RT, whereas PERV RT shows a
significant misincorporation of dATP.
To quantify the capacity of PERV RT to form 3-end
mispairs, four sets of primer-extension reactions were car-
ried out and analyzed (each one with increasing concentra-
tions of a single dNTP), thereby determining the standing-
start rate of synthesis of the correct pair vs the three possible
mispairs. To obey steady-state kinetic conditions, we have
used a range of dNTP concentrations below 1 mM and
calculated the radioactivity in gel bands relative to the total
amounts of primers present (both the unextended and the
extended ones). The apparent Km and Vmax values for each
dNTP derived from the double-reciprocal curves of the
initial velocities of primer extension versus the substrate
concentrations (not shown) are given in Table 5. The fre-
quencies of misinsertion (Fins values) were calculated as
Fins 
Vmax/KmW
Vmax/KmR
, (1)
where W denotes the wrong nucleotide (dATP, dCTP, and
dGTP) and R stands for dTTP (Bakhanashvili and Hizi,
1993a; Rubinek et al., 1997; Taube et al., 1998b). As ex-
pected from the results of Fig. 5A, the highest Fins value
calculated for PERV RT is for dCTP (1/1000), whereas the
formation of A  G mispair is relatively rare (Fins 	
1/92,000) and the Fins value for dATP incorporation is high
(1/5800). In comparison, the Fins values previously calcu-
lated in the same assay system for MLV RT were 1/25,000,

1/300,000, and about 1/300,000 for the formation of A  C,
A  G, and A  A mispairs, respectively (Bakhanashvili and
Hizi, 1993a; Bakhanashvili et al., 1996). This indicates that
PERV RT is significantly more error prone than MLV RT.
Fig. 5. The RNase H activity of PERV and MLV RTs. The RNase H activity of PERV RT and MLV RT was compared with RNase H activity of HIV-1
RT. For each assay, 50 ng of each highly purified RT was incubated with the RNase H substrate (the 5-end-labeled 267 nt RNA and oligomeric DNA) at
37°C, for the indicated times (0.25, 1, and 4 min). The reactions were performed with either Mn2 or with Mg2. The products were resolved by urea–PAGE.
The sizes of the cleavage products were determined using an RNA size markers ladder. The 5-end-labeled RNA marker ladder was prepared by incubating
the 5-end-labeled 267 nt RNA in 10 mM NaOH for 30 s at 50°C (not shown).
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Extension of preformed 3-end mispaired DNA
Misincorporation of a nucleotide, by itself, is not suffi-
cient to create site-specific mutations, unless the mispaired
DNA terminus is further extended to fix the wrong se-
quence. Consequently, the efficiency of extending 3 pre-
formed mismatched primers is an essential factor in deter-
mining the fidelity of DNA synthesis. The ability of PERV
RT to extend preformed 3-end mispaired 16-residue prim-
ers (A  A, A  C, A  G) was measured by analyzing the
extension of these primers, in the presence of the next
complementary dATP—see Fig. 6B. PERV RT elongates
all mispairs with a substantial preference toward the A  C
mispair over the A  G and A  A mispaired DNA. MLV RT
shows a similar preference in extending the mispairs. The
kinetics of the mispair extension was studied by following
primer elongation as a function of increasing concentrations
of dATP (Table 6). The ratios of all extended products were
calculated relatively to the total amount of the primers as a
function of dATP concentration. The relative extension fre-
quency (Fext) values are defined as Vmax/Km values (calcu-
lated for the preformed mismatches) divided by the Vmax/Km
value, obtained for the A  T terminus. The apparent Vmax
values for the extension of all three mispairs studied by
PERV RT are quite similar. As expected, the Km values for
the extension of the A  A, A  C, and A  G mismatches are
much higher than the Km for the correct A  T pair. Most of
the differences in the comparable values result from differ-
ences in the Km values calculated for the mismatches. As
expected, the frequency of extension for A  C is the highest
(1/4250), whereas the frequencies for A  G and A  A are
lower (1/26,000 and 1/40,000, respectively). The Fext values
calculated previously for MLV RT in the same assay system
were 1/4,600, 1/39,400, 1/6,100, for A  C, A  G, and A  A
mispairs, respectively (Bakhanashvili and Hizi, 1993a; Ba-
khanashvili et al., 1996).
Inhibition of the DNA polymerase activity by nucleoside
analogues
All RTs show some sensitivity to nucleoside analogue
inhibitors that serve as DNA chain terminators (since their
incorporation into the 3 end of the nascent DNA strand
blocks further extensions). This sensitivity varies, depend-
ing on the RT studied, on the mutants of every given RT and
on the inhibitor tested. The drugs 3azido-2,3-dideoxythy-
mide (AZT), 2,3-dideoxyinosine (ddI), 2,3-dideoxycyti-
dine (ddC), (-)-2-deoxy-3-thiacytidine (3TC), and 2,3-
didehydro-3-deoxythymidine (d4T), all of which are potent
inhibitors of the RTs of HIV-1 and HIV-2, are among those
used successfully for the treatment of AIDS patients (De
Clercq, 1997). It was shown recently that AZT could inhibit
the replication of PERV virions in infected cells (Stephan et
al., 2001). We have assayed in vitro the polymerase activity
of PERV RT and MLV RT (in comparison with HIV-1 RT),
in the presence of each DNA chain terminator (AZTTP,
ddTTP, and ddGTP). It is apparent that these analogues
inhibit the RDDP activity of PERV RT and MLV RT and
that PERV RT is slightly more sensitive than MLV RT to
Table 6
The kinetics of the extension of 3 end matched or preformed
mismatched primer termini by PERV RT
Pair extended Vmax (%) Km (M) Fext
A  T 30.8 0.018 1
A  C 18.5 46 1/4250
A  G 9.8 150 1/26,000
A  A 15 360 1/40,000
Note. The 5-end-labeled 16-nucleotide primers were hybridized to a
50-nucleotide template (as described for Table 5). The duplexes produced
were 3-terminal paired (A  T) or mispaired (A  C, A  G, or A  A) prim-
ers (Fig. 6B). Each template primer was incubated with PERV RT in the
presence of increasing concentrations of dATP. The products were ana-
lyzed as described in the text. The apparent Km and Vmax values were
determined from at least two independent experiments and the variations
were usually 
10%. The relative frequency Fext values are the ratio of the
rate constants (Vmax/Km) for the mispair divided by the ratio of the corre-
sponding constants for the paired AT terminus.
Table 5
Kinetic parameters for the site-specific misincorporation by PERV RT
Mispair formed Vmax (%) Km (M) Fins
A  T 21.3 0.06 1
A  C 13.6 39 1/1000
A  G 1.3 340 1/92,000
A  A 8.9 145 1/5800
Note. The 15-residue 5-end labeled primer was hybridized to an excess
of 50-residue template derived from the sequence of nucleotides 565–614
of x174am3 DNA (Fig. 6A). In each set of the kinetic experiments, the
template-primer was incubated with PERV RT in the presence of increas-
ing concentrations of a single dNTP. The oligonucleotide products were
analyzed as described under Materials and methods. The apparent Km and
Vmax values were determined from at least two independent experiments
and the variations were usually 
10%. The values of relative frequency of
insertion (Fins) were calculated as described in the text.
Fig. 6. The fidelity of misincorporation and mispair extension of PERV RT. (A) The pattern of site-specific nucleotide misinsertion. The synthetic
50-nucleotide template was annealed to the 32P-5-end-labeled 15-nucleotide primer. The primer was extended with equal DNA polymerase activity of either
PERV RT or MLV RT in the presence of 1 mM of a single incorrect dNTP (i.e., C, G, or A) or 1 M dTTP, as described under Materials and methods.
(B) The pattern of extension of preformed 3 end mispaired DNA. The 32P-5-end-labeled 16-nucleotide primers were hybridized to the 50-nucleotide
template. Four different duplexes were produced, of which three were the 3-terminal preformed mismatches, where N represents the incorrect nucleotide (A,
C, or G) and the fourth is the matched duplex (where N represents T). The primers were extended with equal DNA polymerase activities of PERV RT or
MLV RT, in the presence of either 1 mM dATP (when the mispaired template-primers were elongated) or 1 M dATP (for the extension of the matched
template-primer).
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ddTTP and ddGTP (Fig. 7). However, it is also clear that the
novel PERV RT, similar to MLV RT, is substantially less
sensitive to these inhibitors relative to the well-studied
HIV-1 RT. As judged from the inhibitor concentrations that
lead to inhibition of 50% of the initial DNA polymerase
activity (IC50 values), the sensitivity of the PERV and MLV
RTs to AZTTP was threefold lower than that of HIV-1 RT.
Moreover, the sensitivity of the RTs of PERV and MLV to
ddTTP was 22- to 28-fold lower than the sensitivity of
HIV-1 RT. It is interesting to note that HIV-1 RT shows
relatively close sensitivities to both dTTP analogues—
AZTTP and ddTTP (IC50 values, 14 and 2 nM, respectively).
The other two RTs show a relatively high sensitivity to
AZTTP (IC50 	 6 nM) but a very low sensitivity to ddTTP
(IC50 values of 310–400 nM). This indicates that, unlike
HIV-1 RT, PERV and MLV RTs can incorporate preferen-
tially AZTTP relative to ddTTP. As to the sensitivity to
ddGTP, the PERV and MLV RTs show a substantial resis-
tance relative to HIV-1 RT (IC50 values are 160- to above
360-fold higher than that of HIV-1 RT).
Discussion
The study presented here is devoted to the initial char-
acterization of the properties of the novel recombinant
PERV RT. The putative amino acid sequence of the novel
PERV RT shows high homology to the sequence of the
well-studied MLV RT. Pairwise alignment of the amino
acid sequences of these two RTs yielded a score of 69
(Thompson et al., 1994). Seventy percent of the residues of
PERV RT are identical to those of MLV RT and 15% of the
residues are homologues (Fig. 1). Therefore, we have con-
ducted a comparative study of the catalytic and molecular
properties of these two enzymes. The recombinant PERV
RT resembles in most cases the RT of MLV. Nonetheless,
we found some unique differences in the behavior of these
RTs, which must result from sequence differences. This
comparative study can lead to a better understanding of the
general structure and function of the retroviral RTs. More-
over, due to the potential use of porcine cells, tissues, and
organs as a source for xenogenic therapies and xenotrans-
plantation into humans, this study can also contribute to the
development of improved anti-PERV drugs.
The sensitivity of RTs to nucleoside analogues is well
established; several of the most common drugs against HIV
infections in humans take advantage of HIV RT sensitivity
to these analogues (AZT, 3TC, and ddI). In general, RTs
can be divided into two groups depending on the extent of
their sensitivity to nucleoside analogues. The highly sensi-
tive RTs are those of HIV-1, HIV-2, FIV, and murine
mammary tumor virus (MMTV) (Hizi et al., 1991; North
and La Casse, 1995; Taube et al., 1998a). The less-sensitive
RTs include RTs of mammalian type C retroviruses (such as
MLV), EIAV, and BLV (Hizi et al., 1988; Perach and Hizi,
1999; Rubinek et al., 1994). The present study indicates that
PERV RT, similar to MLV RT, belongs to the second
group. The IC50 values calculated for AZT with these RTs
are only threefold higher than that for HIV-1 RT, while the
values for ddTTP and ddGTP are 22- to 28-fold higher than
those of HIV-1 RT (Fig. 7). The data presented here for the
drug sensitivity of the recombinant PERV RT are compat-
ible with data obtained with two PERV isolates grown in
cell cultures, i.e., PK15 and 293 (Qari et al., 2001). The
isolate designated PERV-B(33)/ATG is the one from which
the recombinant PERV RT was generated. The virion-de-
rived RT shows a reduced sensitivity to all chain termina-
tors tested relative to HIV-1 RT. Only AZT was found to
inhibit also PERV growth in cell cultures (Qari et al., 2001;
Stephan et al., 2001). Relative to other chain terminators
tested, this compound, as in the present study, was found to
be an effective inhibitor of the viral PERV RT (with an IC50
value of only threefold higher than that of the viral HIV
RT). A large-scale production of the new recombinant
PERV RT will allow a massive screening of numerous
compounds for their inhibition of this RT. The similarity in
the behavior of the recombinant and viral versions of PERV
RT strongly supports the validity of using the recombinant
PERV RT for this purpose.
All structural studies on RTs, including three-dimen-
sional crystallography, were conducted so far on the RTs of
HIV-1 and MLV (Ding et al., 1998; Georgiadis et al., 1995;
Steitz, 1993). The subunit composition of the active PERV
RT shows that, similar to MLV RT, it is functionally active
as monomers (Fig. 3). The novel recombinant PERV RT is
a monomer in both the absence and the presence of DNA.
Some of the retroviral RTs studied are hetrodimers (Coffin
et al., 1997; Hizi and Joklik, 1977; Skalka and Goff, 1993),
and others are monomers (Misra et al., 1998; Perach and
Hizi, 1999; Taube et al., 1998a). A recent study suggests
that the reason for the difference in the architectural orga-
nizations of MLV RT and HIV-1 RT lies in a peptide
sequence that is located in the connection domain of MLV
RT and is absent in HIV-1 RT (Pandey et al., 2001). The 27
amino acids long peptide (residues 479–505 in MLV RT)
has a 28 residues homologue in PERV RT (Fig. 1). There-
fore, the data presented here on the monomeric nature of
PERV RT (Fig. 3) are compatible with this study.
In general, PERV RT exhibits lower DNA polymerase-
specific activities than MLV RT with all template-primers
used (in the presence of the preferred divalent cation) (Table
2). However, the RNase H activity of PERV RT is about the
same as that of MLV RT (in the presence of Mn2). It is
apparent also that with all template-primers used, except for
poly(rA)n  oligo(dT)12–18, the DNA polymerase activity of
PERV RT prefers Mg2 over Mn2. MLV RT shows a high
Mg2 -dependent polymerase activity with the exception of
X174 DNA in addition to poly(rA)n  oligo(dT)12–18 (Ta-
ble 2 and Fig. 4). This means that the disparity between the
cation preferences of the two RTs is apparent only with the
template X174 DNA. As also shown, both RTs prefer
Mn2 for their RNase H function.
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Fig. 7. Inhibition of DNA polymerase activity by nucleoside analogues. RDDP activity was assayed with either poly(rA)n  oligo(dT)12–18 and dTTP (for the
inhibitors ddTTP and AZTTP) or poly(rC)n  oligo(dG)12–18 and dGTP (for the analogue, ddGTP). The concentrations of inhibitors leading to a reduction of
50% in the initial polymerase activity (IC50 values) were calculated from the inhibition curves. The IC50 values were calculated each from at least three
independent experiments. (●), PERV RT; (), MLV RT; (Œ), HIV-1 RT.
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The comparison of the amino acid sequences of the
RNase H domains of PERV and MLV RTs reveals a higher
diversity than that seen in the DNA polymerase domains
(only 64% identities and 15% homologies versus 75% iden-
tity and 15% homology, respectively). Nevertheless, it
seems that the properties of the RNase H function of both
RTs are closer than those of the DNA polymerase activity.
Mg2 and Mn2 may bind to the RNase H domain in two
different positions. A two-cation mechanism, similar to that
of the 33 5 exonuclease of DNA polymerase I, has been
suggested also for Escherichia coli RNase H (Steitz, 1993;
Yang et al., 1990). Crystallographic analysis of the RNase H
domain of HIV-1 RT has revealed two Mn2 atoms bound
at the enzyme active site (Davies et al., 1991). Yet, in other
studies, a single Mg2 ion was observed bound at the active
site of E. coli RNase H (Katayanagi et al., 1990, 1993). A
similar one-metal catalytic mechanism for the Mn2-depen-
dent RNase H activity of HIV and MLV RTs was also
shown (Goedken and Marqusee, 1999). The putative metal-
binding residues of the RNase H domain in MLV RT, D524,
E562, and D583 are present also in the PERV RT RNase H
domain (D523, E561, and D582). It was also suggested that
RNase H activity in MLV is directed by an unknown man-
ner by the polymerase domain and that the proper folding of
the RNase H domain of MLV RT requires metal binding
(Goedken and Marqusee, 1998, 1999). As for the DNA
polymerase activity, it is still unclear what the molecular
mechanisms are for the preference for the divalent cation. It
is even more difficult to explain the results presented here
(Table 2), in view of the fluctuation in the cation preferences
as a function of the various template-primers used for as-
saying the polymerase activity.
DNA polymerases which lack the 3 3 5 proofreading
exonuclease activity are more error prone, explaining, at
least in part, why RTs have a lower fidelity than other DNA
polymerases (Bakhanashvili and Hizi, 1993a; Echols and
Goodman, 1991; Perino et al., 1989; Taube et al., 1998b).
Yet, a comparison of the overall fidelity of DNA synthesis
exhibited by RTs from different retroviruses reveals signif-
icant differences among them. The RTs of HIV-1 and
HIV-2 were found to have a relatively low fidelity of DNA
synthesis compared to other RTs, such as avian myeloblas-
tosis virus (AMV), MMTV, EIAV, or MLV (Bakhanashvili
and Hizi 1992; Bakhanashvili et al., 1996; Rubinek et al.,
1997; Taube et al., 1998b; Yu and Goodman, 1992). In
general, the fidelity of DNA polymerases results from the
combination of nucleotide insertion and extension in the
presence or absence of proofreading activity. Base substi-
tution mutations during reverse transcription can arise from
incorporation of a noncomplementary nucleotide at the 3
end of the nascent DNA strand, followed by an extension of
the preformed mispair. We have studied the error proneness
of PERV RT using the defined template-primers and steady-
state kinetics methods previously studied by us in various
RTs. The misinsertion frequencies observed with PERV RT
shows an error proneness higher than that observed with
MLV RT (Fig. 6A and Table 5). Therefore, PERV RT
shows a low fidelity (as low as the fidelity calculated pre-
viously by us for lentiviral RTs) for its misinsertion capac-
ity. As for the capacity of PERV RT to elongate preformed
mispairs, it is apparent from Fig. 6B and Table 6 that PERV
RT exhibits a pattern of extension similar to that observed
with MLV RT. Moreover, the Fext values calculated here
show that the error proneness of the mispair extension by
PERV RT is generally somewhat lower than that of MLV
RT. Since base substitution events can occur only when
further extension of the mismatched DNA strand is allowed,
the overall fidelity of PERV RT is as high as the fidelity of
MLV RT. It should be noted that PERV and MLV RTs
exhibit the highest fidelity of all RTs studied so far.
In all, we hope that the production of large amounts of
enzymatically active recombinant PERV RT will allow a
wide range screening for RT inhibitors and further function-
structure studies. Such studies might be very useful, given
that xenogenic cell therapies and xenotransplantation of
porcine organs into humans will become a feasible medical
practice in the near future.
Materials and methods
Construction of plasmids and proteins purification
The RTs used in this article are recombinant enzymes
expressed in E. coli DH5 and purified from bacterial ex-
tracts. The PERV RT gene was derived from the replication-
competent PERV plasmid pPERV-B(33)/ATG (Czaudera et
al., 2000). The RT gene, designed according to the pairwise
sequence alignment with the MLV pol gene-encoded RT
(Fig. 1), was generated by PCR from the proviral clone
(using the appropriate primers) and was subcloned in
pUC112N6H. The plasmid induces a constitutive overex-
pression of the recombinant protein in bacteria with a six-
histidines tag at its amino-terminus, as shown earlier for
other retroviral RTs (Hizi et al., 1988; Perach and Hizi,
1999; Taube et al., 1998a). The MLV RT was also ex-
pressed in E. coli DH5 (Hizi and Hughes, 1988) with a
similar histidines tag on its amino-terminus and was purified
as described under Results for PERV RT.
Enzymatic assays for DNA polymerase and RNase H
activities
Enzymatic reactions and kinetic studies were performed
following the procedures described previously (Hizi et al.,
1991; Rubinek et al., 1994).
The DNA polymerase activities
These activities were assayed with the following sub-
strates: For the RDDP activity, poly(rA)n  oligo(dT)12–18
was used with [3H]dTTP, poly(rC)n  oligo(dG)12–18 with
[3H]dGTP, and 16S E. coli ribosomal RNA (primed with 15
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residue synthetic primer) was assayed with unlabeled
dGTP, dCTP, dATP, and [3H]dTTP. For the DDDP assay
we have used poly(dA)n  oligo(dT)12–18 with [3H]dTTP,
poly(dC)n  oligo(dG)12–18 with [3H]dGTP, or herring sperm
activated gapped DNA prepared as described previously
(Hizi et al., 1991) or single-stranded X174am3 DNA,
primed with 15 residue synthetic primer, both with unla-
beled dCTP, dATP, dGTP, and [3H]dTTP. Unless otherwise
stated, the final concentration of the synthetic template-
primers was 5 g/ml and of the activated DNA, X174am3
DNA, or ribosomal RNA was 30 g/ml, while the concen-
tration of each dNTP used was 50 M.
The RNase H activity
This activity was assayed by two methods. In the first,
the release of [3H]AMP from [3H]poly(rA)n annealed to
poly(dT)n (into the trichloroacetic acid-soluble fraction)
was measured, as previously described (Hizi et al., 1991). In
the second method, we have followed the pattern of cleav-
age of the labeled 5-end 267-nt RNA, synthesized from the
pBLRA30 plasmid, and annealed to oligomeric DNA
(Sevilya et al., 2001). The reaction mixtures for this assay
contained approximately 0.1 pmol of the 32P-5 -end labeled
RNA transcript, annealed to 0.4 pmol of the 20mer synthetic
oligonucleotide DNA. The 3 end of the DNA oligonucle-
otide is complementary to the region starting 30 nt away
from the 5 end of the RNA transcript. The reactions con-
tained 50 ng of purified PERV RT or MLV RT and were
performed, analyzed, and calculated as described (Sevilya et
al., 2001), except for the fact that the reaction mixtures
contained either MnCl2 or MgCl2 (0.8 or 8 mM, respec-
tively).
Primer extension and processivity experiments
Single-stranded circular X174am3 DNA served as the
template for these studies. This DNA was primed with an
equimolar amount of a 5-end-labeled 15mer oligonucleo-
tide that hybridizes to nt 588–602 of the X174am3 DNA
(Bakhanashvili and Hizi, 1993a). The reactions were per-
formed in 6.6 mM Tris–HCl pH 8.0, 4 mM DTT, 24 g/ml
bovine serum albumin, 30 g/ml template-primer, and 8
mM MgCl2 or 0.8 mM MnCl2. PERV RT and MLV RT,
with equal DNA polymerase activities, were preincubated
with the template-primer for 5 min at 30°C, in the absence
or presence of a DNA trap of a large excess of activated
gapped DNA (at a final concentration of 0.6 mg/ml). All
reactions were initiated immediately by adding the four
dNTPs, each at a final concentration of 20 M, followed by
incubation for 10 min at 37°C. The reactions were stopped
by adding an equal amount of formamide dye mix, dena-
turated at 100°C for 3 min, cooled on ice, and analyzed by
electrophoresis through 8% polyacrylamide–urea in Tris–
borate and EDTA sequencing gels. The extension products
were quantified by densitometric scanning of the gel auto-
radiograms and the amount of primers extended was calcu-
lated (Avidan and Hizi, 1998).
Fidelity of DNA synthesis
The reactions were performed by monitoring the stand-
ing-start misinsertion and mispair extension properties of
the RTs (Bakhanashvili and Hizi, 1993a; Taube et al.,
1998b), using the same buffer as described above for the
processivity studies.
Site-specific nucleotide misinsertion
This function was assayed by following the incorpora-
tion of dNTP opposite to the A residue at position 23 of a
50-nucleotide synthetic template (with a sequence derived
from nucleotides 565–614 of X174am3 DNA) (see Fig.
5A). The 32P-5-end-labeled 15 residues primer was ex-
tended in the presence of increasing concentrations of either
0–1M dTTP or 0–1 mM of each of the incorrect dNTPs
(dATP, dCTP, or dGTP).
Mispair extension
Four sets of 16-residue 32P-5-end-labeled primers were
annealed to the same template used in the misinsertion
assays, producing duplexes with a 3-termini paired (A  T)
or mismatched (A  C, A  G, or A  A) primers. Primer elon-
gation was measured as a function of increasing concentra-
tions of dATP, as the only dNTP present (0–1 mM range for
the mispaired A  A, A  C, or A  G termini, or a 0–1 M
range for the correct A  T terminus).
All fidelity reactions were incubated at 37°C for either 2
min (for the correct incorporation or the extension of the
accurate template-primer) or 5 min (for misincorporation or
extension of preformed mismatched DNA). Kinetic reac-
tions were performed with an about 10-fold molar excess of
template-primer over enzyme to ensure steady-state kinetics
at the linear range. The reaction products were analyzed by
electrophoresis through sequencing gels and the band inten-
sities were quantified.
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